FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

15990111000001107: Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56591701000001118 Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56591801000001110 Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has AMP True Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) 32 tablet 4 x 8 tablets Has AMP True Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has AMP True Co-codamol 8mg/500mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start